Skip to main content
. 2008 Feb 24;29(8):1587–1593. doi: 10.1093/carcin/bgn052

Table I.

Summary of immunohistochemical analysis of CIAPIN1 in adjacent benign liver and HCCs

Immunostaining Adjacent benign liver HCCs (n = 44)
Stage I (n = 6) Stage II (n = 18) Stage III (n = 9) Stage IV (n = 11)
Negative 26/44 (59.1%) 3/6 (50%) 6/18 (30%) 2/9 (22%) 2/11 (18%)
Weak 12/44 (27.3%) 1/6 (17%) 4/18 (22%) 2/9 (22%) 3/11 (27%)
Strong 6/44 (13.6%) 2/6 (33%) 8/18 (45%) 5/9 (56%) 6/11 (55%)